MARKET WIRE NEWS
  1. Home
  2. Stock
  3. AUPH
  4. News
AUPH
Quote
Short
News
Articles
Message Board

Aurinia Pharmaceuticals Inc (NASDAQ : AUPH ) News

News Releases

AUPH News Releases
AUPH : NASDAQ
Business Wire
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
AUPH : NASDAQ
Motley Fool
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million
AUPH : NASDAQ
SeekingAlpha
Aurinia: Cash-Generating Today, Pipeline-Driven Tomorrow
AUPH : NASDAQ
Business Wire
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
AUPH : NASDAQ
SeekingAlpha
Aurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcript
AUPH : NASDAQ
SeekingAlpha
Tang Capital takes 10% stake in Aurinia Pharma
AUPH : NASDAQ
Canada Newswire
TANG CAPITAL MANAGEMENT, LLC FILES EARLY WARNING REPORT RESPECTING AURINIA PHARMACEUTICALS INC.
AUPH : NASDAQ
TMX Newsfile
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences
AUPH : NASDAQ
SeekingAlpha
FDA's Makary On Brink: Why Biotech And Pharma Investors Shouldn't Panic (Or Celebrate)
AUPH : NASDAQ
SeekingAlpha
Aurinia Pharma GAAP EPS of $0.25 beats by $0.05, revenue of $77.7M beats by $0.72M
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.